These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 8074600)
1. Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumonia. Hedlund JU; Kalin ME; Ortqvist AB; Henrichsen J Arch Intern Med; 1994 Sep; 154(17):1961-5. PubMed ID: 8074600 [TBL] [Abstract][Full Text] [Related]
2. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis. Hedlund J Scand J Infect Dis Suppl; 1995; 97():1-60. PubMed ID: 8584866 [TBL] [Abstract][Full Text] [Related]
3. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma. Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530 [TBL] [Abstract][Full Text] [Related]
4. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants. Soininen A; Nohynek H; Lucero M; Jousimies K; Ugpo J; Williams G; Käyhty H; Vaccine; 2009 May; 27(20):2680-8. PubMed ID: 19428879 [TBL] [Abstract][Full Text] [Related]
5. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors. Kapetanovic MC; Roseman C; Jönsson G; Truedsson L; Saxne T; Geborek P Arthritis Rheum; 2011 Dec; 63(12):3723-32. PubMed ID: 21834061 [TBL] [Abstract][Full Text] [Related]
6. Non-response to specific serotypes likely cause for failure to 23-valent pneumococcal polysaccharide vaccine in the elderly. Ortqvist A; Henckaerts I; Hedlund J; Poolman J Vaccine; 2007 Mar; 25(13):2445-50. PubMed ID: 17052816 [TBL] [Abstract][Full Text] [Related]
8. Immune response to a 14-valent pneumococcal polysaccharide vaccine in the elderly. Schouten J Pharmatherapeutica; 1981; 3(1):1-5. PubMed ID: 7323105 [TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of the American Academy of Pediatrics--recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients. Lin PL; Michaels MG; Green M; Mazariegos GV; Webber SA; Lawrence KS; Iurlano K; Greenberg DP Pediatrics; 2005 Jul; 116(1):160-7. PubMed ID: 15995047 [TBL] [Abstract][Full Text] [Related]
10. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Romero-Steiner S; Musher DM; Cetron MS; Pais LB; Groover JE; Fiore AE; Plikaytis BD; Carlone GM Clin Infect Dis; 1999 Aug; 29(2):281-8. PubMed ID: 10476727 [TBL] [Abstract][Full Text] [Related]
11. Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases. Cherif H; Landgren O; Konradsen HB; Kalin M; Björkholm M Vaccine; 2006 Jan; 24(1):75-81. PubMed ID: 16107293 [TBL] [Abstract][Full Text] [Related]
12. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study. Vila-Córcoles A; Ochoa-Gondar O; Hospital I; Ansa X; Vilanova A; Rodríguez T; Llor C; Clin Infect Dis; 2006 Oct; 43(7):860-8. PubMed ID: 16941367 [TBL] [Abstract][Full Text] [Related]
13. Vaccinations in pneumonia (VIP): pneumococcal and influenza vaccination patterns among patients hospitalized for pneumonia. Greci LS; Katz DL; Jekel J Prev Med; 2005 Apr; 40(4):384-8. PubMed ID: 15530591 [TBL] [Abstract][Full Text] [Related]
14. Antibody response to pneumococcal capsular polysaccharide vaccination in patients with chronic kidney disease. Mahmoodi M; Aghamohammadi A; Rezaei N; Lessan-Pezeshki M; Pourmand G; Mohagheghi MA; Abdollahzade S; Mousavi-Jarrahi A Eur Cytokine Netw; 2009 Jun; 20(2):69-74. PubMed ID: 19541592 [TBL] [Abstract][Full Text] [Related]
15. Pneumococcal seroconversion after vaccination for children with atopic dermatitis treated with tacrolimus ointment. Stiehm ER; Roberts RL; Kaplan MS; Corren J; Jaracz E; Rico MJ J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S206-13. PubMed ID: 16021176 [TBL] [Abstract][Full Text] [Related]
16. Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years. Manoff SB; Liss C; Caulfield MJ; Marchese RD; Silber J; Boslego J; Romero-Steiner S; Rajam G; Glass NE; Whitney CG; Carlone GM J Infect Dis; 2010 Feb; 201(4):525-33. PubMed ID: 20088694 [TBL] [Abstract][Full Text] [Related]
17. Antibody response to pneumococcal vaccine in splenectomized children. Pedersen FK Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):169-80. PubMed ID: 6880749 [TBL] [Abstract][Full Text] [Related]
19. Antibody levels and response to pneumococcal vaccine in steroid-dependent asthma. Lahood N; Emerson SS; Kumar P; Sorensen RU Ann Allergy; 1993 Apr; 70(4):289-94. PubMed ID: 8466093 [TBL] [Abstract][Full Text] [Related]
20. Impact of the pneumococcal vaccine on long-term morbidity and mortality of adults at high risk for pneumonia. Johnstone J; Eurich DT; Minhas JK; Marrie TJ; Majumdar SR Clin Infect Dis; 2010 Jul; 51(1):15-22. PubMed ID: 20504233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]